rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt]
- RxCUI
- 828537
- RxNorm name
- rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt]
- Display name
- rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt]
- Full name
- rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MAXALT | RIZATRIPTAN BENZOATE | Organon LLC | 007b4644-e0e7-4863-9ae3-fe09676b3f5f | 2026-01-29 | Warnings, Adverse reactions | 828537 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 007b4644-e0e7-4863-9ae3-fe09676b3f5f | Maxalt-MLT 10 MG Disintegrating Oral Tablet [PSN] · rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt] [SBD] · Maxalt 10 MG Disintegrating Oral Tablet [SY] · Maxalt-MLT 10 MG Disintegrating Oral Tablet [SY] | 4 | 4 | These highlights do not include all the information needed to use MAXALT and MAXALT-MLT safely and effectively. See full prescribing information for MAXALT and MAXALT-MLT. MAXALT ® (rizatriptan benzoate) tablets, for oral use MAXALT-MLT ® (rizatriptan benzoate) orally disintegrating tablets Initial U.S. Approval: 1998 | 20260129 |
| 3756d8e3-7e89-46c7-8723-6fea65363913 | Maxalt-MLT 10 MG Disintegrating Oral Tablet [PSN] · rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt] [SBD] · Maxalt 10 MG Disintegrating Oral Tablet [SY] · Maxalt-MLT 10 MG Disintegrating Oral Tablet [SY] | 4 | 2 | These highlights do not include all the information needed to use MAXALT and MAXALT-MLT safely and effectively. See full prescribing information for MAXALT and MAXALT-MLT. MAXALT (rizatriptan benzoate) tablets, for oral use MAXALT-MLT (rizatriptan benzoate) orally disintegrating tablets Initial U.S. Approval: 1998 | 20120314 |